Cytomx Therapeutics
Clinical trials sponsored by Cytomx Therapeutics, explained in plain language.
-
New hope for advanced cancers: first human trial launched
Disease control Recruiting nowThis study tests a new drug, CX-2051, in adults with advanced solid tumors that have not responded to standard treatments. The goal is to check the drug's safety and see if it can shrink tumors. About 160 participants will receive the drug alone or with another medicine called be…
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:32 UTC
-
New drug combo aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis early study tests a new drug called CX-801, alone or with another drug (pembrolizumab), in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the best dose. About 121 people will take part.
Phase: PHASE1 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated May 17, 2026 00:30 UTC